Skip to main content
Equibles

BOOTHBAY FUND MANAGEMENT, LLC

Position in IMUX — Immunic, Inc.

CIK 1549230 NEW YORK, NY
Back to IMUX Full portfolio

Position in IMUX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$200,686
+$130,954 QoQ
Shares Held
13,057
-0.0% QoQ
Ownership
0.096%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 55 holders
Holding Since
Sep 2021
16 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in IMUX Over Time

Shares Held

Position Value (USD)

Derivatives in IMUX

reported options exposure · as of Mar 31, 2025
CallValue
$200,887
CallShares
18,430
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BOOTHBAY FUND MANAGEMENT, LLC holds $666,641,771 across 159 Biotechnology names. IMUX ranks #131 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 465,787 $87,232,589
2 ABVX
Abivax S.A.
 563,367 $75,074,286
3 EXEL
Exelixis, Inc.
 804,095 $43,750,808
4 PCVX
Vaxcyte, Inc.
 534,163 $31,050,895
5 COGT
Cogent Biosciences, Inc.
 692,825 $26,812,327
6 CGEM
Cullinan Therapeutics, Inc.
 1,082,611 $19,714,346
7 TNGX
Tango Therapeutics, Inc.
 500,497 $15,645,536
8 AVTX
Avalo Therapeutics, Inc.
 702,051 $12,973,902

All Filings in IMUX

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $200,686 13,057
2025-12-31 $69,732 130,585
2025-09-30 $212,449 240,873
2025-06-30 $168,129 240,873
2025-03-31 $262,551 240,873
2025-03-31 $200,887 184,300
2024-12-31 $184,300 184,300
2024-12-31 $425,314 425,314
2024-09-30 $698,811 423,522
2024-06-30 $470,109 423,522
2024-03-31 $559,049 423,522
2023-12-31 $121,636 81,091
2023-09-30 $119,203 81,091
2023-06-30 $293,996 117,130
2023-03-31 $174,523 117,130
2022-12-31 $163,982 117,130
2022-06-30 $61,873 17,831
2021-09-30 $154,600 17,469